Q1 2016 Holdings
Filed 2016-05-13 | 22 holdings | $43.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $13.4M | 721,152 | 31.0% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $13.3M | 4,689,435 | 30.7% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $7.4M | 577,831 | 17.2% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $5.5M | 259,259 | 12.7% |
| BeiGene Ltd(ONC) | COM | 07725L102 | $3.5M | 119,000 | 8.1% |
| AveXis Inc | COM | 05366U100 | $24.5K | 1,035,657 | 0.1% |
| Edge Therapeutics Inc | COM | 279870109 | $17.7K | 1,933,582 | 0.0% |
| DBV Technologies | COM | F2927N109 | $12.2K | 214,417 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $11.1K | 1,030,954 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $7.7K | 405,901 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $5.2K | 369,490 | 0.0% |
| Axovant Sciences Ltd | COM | G0750W104 | $4.9K | 429,590 | 0.0% |
| Alcobra Ltd | COM | M2239P109 | $4.3K | 1,130,500 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $4.3K | 420,000 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $3.7K | 1,078,932 | 0.0% |
| Cynapsus Therapeutics Inc | COM | 23257Y701 | $3.1K | 253,345 | 0.0% |
| Ocera Therapeutics | COM | 67552A108 | $2.8K | 948,372 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $2.7K | 170,312 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $1.5K | 315,980 | 0.0% |
| Avalanche Biotechnologies Inc | COM | 05337G107 | $1.4K | 280,000 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $945 | 141,479 | 0.0% |
| ProNAI Therapeutics Inc | COM | 74346L101 | $882 | 130,798 | 0.0% |